Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Manufacturers’ Anticounterfeiting Plans Sought In House Cmte. Investigation

Executive Summary

The House Energy & Commerce Committee is asking five brand-name drug manufacturers to submit information on their efforts to prevent counterfeiting

You may also be interested in...



Lilly anticounterfeit measures

Lilly is exploring use of radio frequency identification on its products in pilot programs as part of multi-pronged anticounterfeit strategy. Other measures include Canadian supply allocation program, direct-buying requirement for wholesalers, and establishment of a global product protection division. The company's Feb. 5 press release describing the measures will be submitted to House Energy & Commerce Committee as requested under its counterfeit drug investigation (1"The Pink Sheet" Jan. 19, 2004, p. 13). Lilly's Zyprexa, Cialis and insulin products have been the subject of counterfeit concerns...

Lilly anticounterfeit measures

Lilly is exploring use of radio frequency identification on its products in pilot programs as part of multi-pronged anticounterfeit strategy. Other measures include Canadian supply allocation program, direct-buying requirement for wholesalers, and establishment of a global product protection division. The company's Feb. 5 press release describing the measures will be submitted to House Energy & Commerce Committee as requested under its counterfeit drug investigation (1"The Pink Sheet" Jan. 19, 2004, p. 13). Lilly's Zyprexa, Cialis and insulin products have been the subject of counterfeit concerns...

Illegal Internet Pharmacy “Enablers” To Be Subject Of House Hearings

The House Energy & Commerce Committee expects to hold hearings early next year on the role of credit card companies and shipping services in enabling illegal Internet pharmacies

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS043176

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel